Literature DB >> 9013738

Intraventricular leptin reduces food intake and body weight of lean rats but not obese Zucker rats.

R J Seeley1, G van Dijk, L A Campfield, F J Smith, P Burn, J A Nelligan, S M Bell, D G Baskin, S C Woods, M W Schwartz.   

Abstract

The protein encoded by the obese (ob) gene, leptin, is secreted from adipose tissue and is proposed to act in the brain as an important regulator of food intake and body weight. To investigate the direct effects of leptin within the CNS, we injected 3.5 microg of either mouse or human leptin into the third ventricle (ICV) of lean Long-Evans rats or obese (fa/fa) Zucker rats, in which obesity results from a mutation in the leptin receptor gene. ICV administration of leptin reduced 4-h food intake in both deprived and non-deprived lean rats. In addition, repeated ICV administration produced a long-lasting reduction in body weight while peripheral administration of the same dose had no effect. ICV administration of the same dose of leptin into the third ventricle of obese Zucker rats did not reduce food intake. These results are consistent with the hypothesis that leptin has direct actions in the CNS as an afferent signal related to the state of energy stores in adipose tissue. Furthermore, insensitivity to these central effects of leptin may be an important determinant of obesity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9013738     DOI: 10.1055/s-2007-979874

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  43 in total

1.  Short-term treatment with estrone oleate in liposomes (Merlin-2) does not affect the expression of the ob gene in Zucker obese rats.

Authors:  C Adán; M M Grasa; C Cabot; M Esteve; R Vilà; R Masanés; J Estruch; J A Fernández-López; X Remesar; M Alemany
Journal:  Mol Cell Biochem       Date:  1999-07       Impact factor: 3.396

2.  Disruption of hypothalamic leptin signaling in mice leads to early-onset obesity, but physiological adaptations in mature animals stabilize adiposity levels.

Authors:  Laurence E Ring; Lori M Zeltser
Journal:  J Clin Invest       Date:  2010-07-01       Impact factor: 14.808

3.  GM-CSF action in the CNS decreases food intake and body weight.

Authors:  Jacquelyn A Reed; Deborah J Clegg; Kathleen Blake Smith; Emeline G Tolod-Richer; Emily K Matter; Lara S Picard; Randy J Seeley
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

4.  Catestatin (chromogranin A(352-372)) and novel effects on mobilization of fat from adipose tissue through regulation of adrenergic and leptin signaling.

Authors:  Gautam K Bandyopadhyay; Christine U Vu; Stefano Gentile; Howon Lee; Nilima Biswas; Nai-Wen Chi; Daniel T O'Connor; Sushil K Mahata
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

Review 5.  Pancreatic signals controlling food intake; insulin, glucagon and amylin.

Authors:  Stephen C Woods; Thomas A Lutz; Nori Geary; Wolfgang Langhans
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

Review 6.  Neuropeptide Y in normal eating and in genetic and dietary-induced obesity.

Authors:  B Beck
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

Review 7.  Hypothalamic control of energy and glucose metabolism.

Authors:  Stephanie Sisley; Darleen Sandoval
Journal:  Rev Endocr Metab Disord       Date:  2011-09       Impact factor: 6.514

8.  Rapid inhibition of neural excitability in the nucleus tractus solitarii by leptin: implications for ingestive behaviour.

Authors:  K W Williams; B N Smith
Journal:  J Physiol       Date:  2006-03-31       Impact factor: 5.182

9.  Arcuate nucleus proopiomelanocortin neurons mediate the acute anorectic actions of leukemia inhibitory factor via gp130.

Authors:  Aaron J Grossberg; Jarrad M Scarlett; XinXia Zhu; Darren D Bowe; Ayesha K Batra; Theodore P Braun; Daniel L Marks
Journal:  Endocrinology       Date:  2009-12-16       Impact factor: 4.736

10.  The 6th Annual World Congress on the insulin resistance syndrome.

Authors:  Zachary T Bloomgarden
Journal:  Diabetes Care       Date:  2009-09       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.